Assistant Professor for Clinical and Experimental Neuroimmunology
2011
Ruhr-University Bochum, Germany
Associate Professor
2018
Ruhr-University Bochum, Germany
Education/professional experience
From
To
Place
Medical School
1992
1999
University of Erlangen-Nürnberg, Germany
Resident
2000
2003
Department of Neurology, University of Regensburg, Germany
Research fellow
2003
2004
Institute of Genetics, University of Cologne, Germany
Resident, since 2007 attending
2004
2011
Department of Neurology, University of Regensburg, Germany
Attending (consultant)
2011
2017
Department of Neurology, Ruhr-University Bochum, Germany
Medical Director
2017
Ongoing
Marianne-Strauß-Klinik, Germany
Membership of medical scientific societies / consortia
Since
2003
Deutsche Gesellschaft für Neurologie (DGN), Germany
2008
Deutsche Gesellschaft für Klinische Neurophysiologie (DGKN), Germany Certificates: EMG, EP, Ultrasound
2009
Neuromyelitis optica study group (NEMOS), Germany
2013
International Clinical Consortium, Guthy Jackson Foundation, Los Angeles, USA
Selected publications
Yamamura T, Kleiter I, Fujihara K, Palace J, Greenberg B, Zakrzewska-Pniewska B, Patti F, Tsai CP, Saiz A, Yamazaki H, Kawata Y, Wright P, De Seze J. Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder. NEJM 2019 Nov 28;381(22):2114-2124.
Kleiter I, Gahlen A, Borisow N, …,NEMOS (Neuromyelitis Optica Study Group). Apheresis therapies for NMOSD attacks: a retrospective study of 207 therapeutic interventions. Neurol Neuroimmunol Neuroinflamm 2018 Sep 26;5(6):e504.
Kleiter I, Gahlen A, Borisow N, …, NEMOS (Neuromyelitis Optica Study Group). Therapy of neuromyelitis optica exacerbations: a retrospective evaluation of 871 attacks and 1153 treatment courses. Ann Neurol 2016; 79: 206-216.
Stellmann J, Krumbholz M, Friede T, …, Kleiter I. Immunotherapies in neuromyelitis optica spectrum disorder: Efficacy and predictors of response. J Neurol Neurosurg Psychiatry 2017;88(8):639-647
Ringelstein M, Ayzenberg I, Harmel J, Lauenstein AS, Lensch E, Stogbauer F, Hellwig K, Ellrichmann G, Stettner M, Chan A, Hartung HP, Kieseier B, Gold R, Aktas O, Kleiter I. Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder. JAMA Neurol. 2015; 72: 756-63.